Calif. company developing bioartificial liver gets $22.5M boost

06/25/2013 | MassDevice.com (Boston)

Vital Therapies has secured $22.5 million in a round of financing from 15 investors. The San Diego company will use the money to further develop its ELAD bioartificial liver, which could provide continuous liver support for patients being treated for hepatitis B, alcohol hepatitis and acute organ failure.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI